ArticleThe Journal of investigative dermatology2026
Defensins Mediate Skin Inflammation and Itch in Psoriasis.
Article in The Journal of investigative dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Psoriasis is an inflammatory skin condition that features marked upregulation of keratinocyte-derived antimicrobial peptides, particularly β-defensins. Yet the functions of these peptides in skin inflammation remain unclear. In this study, we used a Defensin cluster knockout mouse to evaluate the potential roles of defensins as neuroimmune modulators in psoriasis. Deletion of the defensin gene cluster (Def cKO) in keratinocytes significantly attenuated imiquimod-induced psoriatic inflammation, with reduced hyperkeratosis, erythema, scaling, and expression of inflammatory cytokines and chemokines. Additionally, the Def cKO mice exhibited reduced neutrophil and IL-17+ TCRγδ T cell infiltration in the psoriatic skin, indicating a critical role of defensins in amplifying Th17 immunity. Behavioural analysis further revealed that loss of defensins reduced psoriatic itch, and we showed that human β-defensin 2 directly activated small-diameter Mrgpra3 neurons to elicit robust scratching. Overall, our study revealed that β-defensins play an important role in mediating inflammation and itch associated with psoriasis by activating neutrophils, type 17 immune response, and pruriceptive sensory neurons, suggesting defensin signalling as a potential therapeutic target in psoriasis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.